Table 3 Initial respiratory data
Primary immunodeficiencies (n = 20) | Idiopathic and post infectious (n = 39) | Other etiologies (n = 39) | All (n = 98) | P value | |
|---|---|---|---|---|---|
Lung function | |||||
FEV1 (L) | 1.89 [1.59–2.56] | 1.56 [1.16–2.09] | 1.68 [1.28–2.34] | 1.73 [1.28–2.20] | 0.22 |
FEV1 (% predicted) | 75.5 [57.25–92.5] | 73 [54–90] | 66 [51–92] | 73.5 [53.75–90.5] | 0.53 |
FEV1/VC (%) | 67 [55–76.25] | 62 [52–75] | 64 [55–71] | 64 [55–74] | 0.71 |
FEV1/VC < 70% | 12 (60%) | 24 (61.5%) | 27 (69.2%) | 63 (64.3%) | 0.70 |
RV/TLC > 30% | 20 (100%)* | 30 (77%)* | 35 (89.7%) | 85 (86.7%) | 0.002 |
Bhalla score | 9 [6;11] | 9 [7;11] | 9 [7;12] | 9 [7;11] | 0.55 |
FACED score | 0.6 | ||||
Mild (0–2) | 16 (80%) | 23 (59%) | 27 (69.2%) | 66 (67.3%) | |
Moderate (3–4) | 3 (15%) | 12 (30.8%) | 9 (23.1%) | 24 (24.4%) | |
Severe (5–7) | 1 (5%) | 4 (10.3%) | 3 (7.7%) | 8 (8.3%) | |